Antonin Levy

11PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyAged care nursing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 26, 2026
AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.

|Jul 17, 2026
RAS signaling at the crossroads of radioresistance and tumor immunity.

|Jun 16, 2026
Redefining Radiotherapy: The Gut as an Active Target in Immuno-oncology.

|Oct 09, 2025
Unresectable stage III non-small-cell lung cancer: state of the art and challenges.

Jordi Remon, Antonin Levy, Romane Gille

|Jun 30, 2025
Low-dose radiotherapy enhances the efficacy of PD-L1 blockade and induces the abscopal effect.

Pierre-Antoine Laurent, Liu Shi, Lisa Bouarroudj

|Mar 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results.

Antonin Levy, Daphné Morel, Matthieu Texier

Pageof 2

Frequent Collaborators

3 joint publications

Eric Deutsch

1 joint publications

Olaf Mercier

1 joint publications

Cécile Le Péchoux

1 joint publications

Egesta Lopci